0
Your cart

Your cart is empty

Books

Buy Now

Screening and Risk Reduction Strategies for Breast Cancer - Imaging Modality and Risk-Reduction Approaches (Hardcover, 1st ed. 2023) Loot Price: R4,264
Discovery Miles 42 640
Screening and Risk Reduction Strategies for Breast Cancer - Imaging Modality and Risk-Reduction Approaches (Hardcover, 1st ed....

Screening and Risk Reduction Strategies for Breast Cancer - Imaging Modality and Risk-Reduction Approaches (Hardcover, 1st ed. 2023)

Masakazu Toi

 (sign in to rate)
Loot Price R4,264 Discovery Miles 42 640 | Repayment Terms: R400 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening. A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book.  An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.

General

Imprint: Springer Verlag, Singapore
Country of origin: Singapore
Release date: March 2023
First published: 2023
Editors: Masakazu Toi
Dimensions: 254 x 178mm (L x W)
Format: Hardcover
Pages: 189
Edition: 1st ed. 2023
ISBN-13: 978-981-19-7629-2
Categories: Books
LSN: 981-19-7629-5
Barcode: 9789811976292

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners